Sign in
8-K

Current Report

Keros Therapeutics, Inc. Filed Acc 0001664710-26-000008

Executive or director change · Regulation FD disclosure

  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading kros-20260220.htm…